William Garrett Nichols, Chief Medical Officer at Candel Therapeutics, Inc. (CADL), sold 937 shares at $6.98 ($7K) on 2025-07-28, disclosed to the SEC on 2025-07-30.
Scheduled sale ($7k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CADL | SELL | 2025-01-17 | $151K | — | Filing → |
| CADL | SELL | 2025-01-10 | $178K | — | Filing → |
| CADL | SELL | 2024-12-03 | $127K | — | Filing → |